2024-09-06 - Analysis Report
## TMO Stock Analysis Report

**Company Overview:** TMO, Thermo Fisher Scientific Inc., is a leading provider of scientific instrumentation, consumables, and services to the pharmaceutical and life sciences industries.

**Performance Analysis:**

**1. Return vs. S&P 500:**

* **Cumulative Return:** TMO (114.73%) significantly outperformed the S&P 500 (VOO) (89.66%).
* **Relative Strength:** TMO's performance is currently 29.58% higher than the S&P 500, indicating a strong outperformance relative to the broader market.

**2. Recent Price Movements:**

* **Closing Price:** $615.07
* **5-day Moving Average:** $611.18
* **20-day Moving Average:** $604.74
* **60-day Moving Average:** $578.32

The stock price is trading above all three moving averages, indicating a bullish trend in the short and mid-term.

**3. Technical Indicators:**

* **RSI:** 67.56 - TMO is currently in overbought territory, suggesting a potential pullback in the short term.
* **PPO:** -0.13 - This indicates a slight bearish momentum.
* **Delta_Previous_Relative_Divergence:** -11.79 -  TMO's relative strength has weakened recently, suggesting a short-term downward trend.
* **Expected Return:** 61.82% - This is the expected return on investment over 5 years, based on current market conditions.

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | $10.54B |
| 2024-05-03 | 3.47 | $10.35B |
| 2023-11-03 | 4.44 | $10.57B |
| 2023-08-04 | 3.53 | $10.69B |
| 2024-08-02 | 3.53 | $10.69B |

TMO's most recent earnings report on 2024-08-02 beat analysts' expectations with an EPS of 4.05, exceeding the estimated 3.82. Revenue also surpassed forecasts at $10.54B, compared to the expected $10.42B. This indicates strong growth and performance for the company.

**5. Summary:**

* TMO has outperformed the S&P 500 significantly, showing strong relative strength.
* The stock price is trading above all moving averages, indicating a positive short-term outlook.
* Technical indicators suggest a slight bearish sentiment, with RSI in overbought territory and a recent decline in relative strength. 
* The most recent earnings report beat analysts' expectations, indicating strong performance and a positive outlook for the company. 

**Overall, TMO remains a strong performer with solid fundamentals and positive growth prospects. However, the recent overbought condition and weakening relative strength suggest a potential short-term pullback. Investors may consider holding their positions while monitoring market trends and upcoming earnings reports.**
